R. Calvo

684 total citations
47 papers, 538 citations indexed

About

R. Calvo is a scholar working on Anesthesiology and Pain Medicine, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, R. Calvo has authored 47 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Anesthesiology and Pain Medicine, 10 papers in Pharmacology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in R. Calvo's work include Anesthesia and Sedative Agents (13 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). R. Calvo is often cited by papers focused on Anesthesia and Sedative Agents (13 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). R. Calvo collaborates with scholars based in Spain, United States and Canada. R. Calvo's co-authors include Elena Suárez, Iñaki F. Trocóniz, S. Erill, Marı́a J. Garrido, Marta Valle, C Aguirre, Miren Zamacona, Luciano Aguilera, Carolina Aguirre and M. A. Campanero and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Anesthesia & Analgesia and British Journal of Anaesthesia.

In The Last Decade

R. Calvo

46 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Calvo Spain 14 189 88 88 83 66 47 538
Elena Suárez Spain 14 161 0.9× 148 1.7× 98 1.1× 98 1.2× 90 1.4× 59 659
P. J. M. Guelen Netherlands 14 110 0.6× 65 0.7× 63 0.7× 52 0.6× 35 0.5× 40 581
J. A. Jansen Denmark 16 103 0.5× 125 1.4× 63 0.7× 87 1.0× 78 1.2× 30 656
Kathy Cox United States 10 161 0.9× 58 0.7× 181 2.1× 28 0.3× 68 1.0× 17 455
Marie‐Odile Richard France 14 115 0.6× 281 3.2× 126 1.4× 43 0.5× 64 1.0× 41 663
Katayoun Zomorodi United Kingdom 11 301 1.6× 49 0.6× 173 2.0× 34 0.4× 69 1.0× 12 589
R. G. Moore Australia 15 78 0.4× 130 1.5× 55 0.6× 35 0.4× 100 1.5× 20 528
R Hurkmans Belgium 9 86 0.5× 60 0.7× 80 0.9× 74 0.9× 58 0.9× 12 331
P J Pentikäinen Finland 14 42 0.2× 47 0.5× 129 1.5× 90 1.1× 77 1.2× 32 790
A. Hutchings United Kingdom 14 40 0.2× 51 0.6× 90 1.0× 61 0.7× 34 0.5× 19 354

Countries citing papers authored by R. Calvo

Since Specialization
Citations

This map shows the geographic impact of R. Calvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Calvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Calvo more than expected).

Fields of papers citing papers by R. Calvo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Calvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Calvo. The network helps show where R. Calvo may publish in the future.

Co-authorship network of co-authors of R. Calvo

This figure shows the co-authorship network connecting the top 25 collaborators of R. Calvo. A scholar is included among the top collaborators of R. Calvo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Calvo. R. Calvo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lukas, John C., Ana Suárez, María Victoria Martínez Calvo, et al.. (2005). Time-dependent pharmacokinetics of cyclosporine (NeoralR) in de novo renal transplant patients. Journal of Clinical Pharmacy and Therapeutics. 30(6). 549–557. 16 indexed citations
2.
Calvo, R., et al.. (2004). Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients. Acta Anaesthesiologica Scandinavica. 48(8). 1038–1048. 14 indexed citations
3.
Garrido, Marı́a J., Carolina Aguirre, Iñaki F. Trocóniz, et al.. (2000). Alpha1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome. International Journal of Clinical Pharmacology and Therapeutics. 38(1). 35–40. 28 indexed citations
4.
Zamacona, Miren, Elena Suárez, Estefanía García, C Aguirre, & R. Calvo. (1998). The Significance of Lipoproteins in Serum Binding Variations of Propofol. Anesthesia & Analgesia. 87(5). 1147–1151. 8 indexed citations
5.
Aguirre, C, et al.. (1996). THE EFFECT OF CHANGES IN GASTRIC pH INDUCED BY OMEPRAZOLE ON THE ABSORPTION AND RESPIRATORY DEPRESSION OF METHADONE. Biopharmaceutics & Drug Disposition. 17(7). 551–563. 15 indexed citations
6.
Calvo, R., et al.. (1996). Paracetamol metabolism in two ethnically different Spanish populations. European Journal of Drug Metabolism and Pharmacokinetics. 21(3). 233–239. 11 indexed citations
7.
Calvo, R., et al.. (1996). Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis. Acta Anaesthesiologica Scandinavica. 40(6). 741–745. 40 indexed citations
8.
Valle, Marta, et al.. (1996). Characteristics of serum protein binding of felodipine.. PubMed. 94(1). 73–88. 6 indexed citations
9.
Suárez, Elena, et al.. (1995). Altered methadone analgesia due to changes in plasma protein binding: Role of the route of administration. General Pharmacology The Vascular System. 26(6). 1273–1276. 11 indexed citations
10.
Torres, Isabel, et al.. (1995). Differential effect of cancer on the serum protein binding of mianserin and imipramine. European Journal of Drug Metabolism and Pharmacokinetics. 20(2). 107–111. 4 indexed citations
11.
García, Emilio García, et al.. (1995). Resistance to atracurium in rats with experimental inflammation: role of protein binchng. Acta Anaesthesiologica Scandinavica. 39(8). 1019–1023. 13 indexed citations
12.
Garrido, Marı́a J., et al.. (1995). [Characterization of propofol binding to plasma proteins and possible interactions].. PubMed. 41(6). 308–12. 6 indexed citations
13.
Valdivieso, Andrés, et al.. (1993). Propranolol Absorption in Peptic Ulcer Disease. Scandinavian Journal of Gastroenterology. 28(7). 643–646. 2 indexed citations
14.
García, Estefanía, et al.. (1992). In vivopotentiation of atracurium neuromuscular blockade by nimodipine in rabbits. Acta Anaesthesiologica Scandinavica. 36(1). 67–69. 6 indexed citations
15.
Souich, Patrick du, R. Calvo, & S. Erill. (1990). Effects of cefotaxime on the serum protein binding of sulfisoxazole. Biopharmaceutics & Drug Disposition. 11(5). 371–379. 2 indexed citations
16.
Jordà, R., et al.. (1990). Decrease in Penbutolol Central Response as a Cause of Changes in its Serum Protein Binding. Journal of Pharmacy and Pharmacology. 42(3). 164–166. 7 indexed citations
17.
Calvo, R., et al.. (1989). Displacement of warfarin from human serum proteins by halothane anaesthesia. Acta Anaesthesiologica Scandinavica. 33(7). 575–577. 5 indexed citations
18.
Calvo, R., et al.. (1988). Plasma protein binding of penbutolol in pregnancy. European Journal of Drug Metabolism and Pharmacokinetics. 13(1). 23–26. 8 indexed citations
19.
Calvo, R., et al.. (1988). Effect of sodium valproate on midazolam distribution. Journal of Pharmacy and Pharmacology. 40(2). 150–152. 6 indexed citations
20.
Calvo, R., et al.. (1982). Effects of Carbamylation of Plasma Proteins and Competitive Displacers on Drug Binding in Uremia. Pharmacology. 24(4). 248–252. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026